Similarly, α-asarone treatment increased acetylcholinesterase (AChE) activity and normalised MDA and SOD levels in the hippocampus and cerebral cortex of AD-like scopolamine-induced amnesic mice [76]. This evidence concerns the gene ACHE and Alzheimer disease.